{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:18:59Z","timestamp":1794327539050,"version":"4.9.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.radonc.2023.110060","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T04:22:30Z","timestamp":1702959750000},"page":"110060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)"],"prefix":"10.1016","volume":"195","author":[{"given":"Orit","family":"Kaidar-Person","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icro","family":"Meattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth J.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Becherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare M.","family":"Isacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Vestm\u00f8 Maraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Marangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Nader Marta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvil","family":"Mjaaland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Salvestrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Spanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Visani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Livi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte V.","family":"Offersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.110060_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109724","article-title":"Introducing the ESTRO Guidelines Committee, driving force for the new generation of ESTRO guidelines","author":"McDonald","year":"2023","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2012.03.010","article-title":"ESTRO 2012 strategy meeting: vision for radiation oncology","volume":"103","author":"Valentini","year":"2012","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1118\/1.597316","article-title":"Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40","volume":"21","author":"Kutcher","year":"1994","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.110060_b0020","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2007.08.080","article-title":"Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on \u201cquality assurance of radiation therapy: challenges of advanced technology\u201d","volume":"71","author":"Williamson","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110060_b0025","unstructured":"Thwaites DI, Mijnheer BJ, Mills JA. Quality assurance of external beam radiotherapy. International Atomic Energy Agency (IAEA): IAEA; 2005."},{"key":"10.1016\/j.radonc.2023.110060_b0030","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ijrobp.2007.08.083","article-title":"Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials","volume":"71","author":"Ibbott","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110060_b0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2021.11.018","article-title":"The radiotherapy quality assurance gap among phase III cancer clinical trials","volume":"166","author":"Corrigan","year":"2022","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2022.05.006","article-title":"The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922\/10925 randomised trial","volume":"172","author":"Kaidar-Person","year":"2022","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19800701)46:1<1::AID-CNCR2820460102>3.0.CO;2-3","article-title":"Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome","volume":"46","author":"Fisher","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.110060_b0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2023.110060_b0055","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0060","doi-asserted-by":"crossref","unstructured":"Overgaard M, Nielsen HM, Tramm T, H\u00f8jris I, Grantzau TL, Alsner J, et al. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the danish breast cancer cooperative group DBCG 82bc trial. Radiother Oncol : J Eur Soc Therap Radiol Oncol. 2022.","DOI":"10.1016\/j.radonc.2022.03.008"},{"key":"10.1016\/j.radonc.2023.110060_b0065","doi-asserted-by":"crossref","first-page":"GS4-02","DOI":"10.1158\/1538-7445.SABCS18-GS4-02","article-title":"Abstract GS4-02: Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials","volume":"79","author":"Dodwell","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2023.110060_b0070","first-page":"118","article-title":"Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial","volume":"28","author":"Thomsen","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","article-title":"Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy","volume":"82","author":"Donovan","year":"2007","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2022.09.024","article-title":"Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial","volume":"177","author":"Thomsen","year":"2022","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0085","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.110060_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(22)00145-0","article-title":"Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study","author":"Thiruchelvam","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2023.110060_b0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.breast.2023.01.002","article-title":"Omission of axillary sentinel lymph node biopsy in early invasive breast cancer","volume":"67","author":"Reimer","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2023.110060_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109805","article-title":"Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis","volume":"186","author":"Salvestrini","year":"2023","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102586","article-title":"Safety profile of cyclin-dependent kinase (CDK) 4\/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis","volume":"119","author":"Becherini","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.110060_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102417","article-title":"Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside","volume":"108","author":"Meattini","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.110060_b9000","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S1470-2045(23)00534-X","article-title":"International multidisciplinary consensus on the integration of radiotherapy with new systematic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations","volume":"25","author":"Meattini","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2014.08.029","article-title":"Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey","volume":"112","author":"Grau","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2004.12.007","article-title":"Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project","volume":"75","author":"Bentzen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2020.11.009","article-title":"Development of staffing, workload and infrastructure in member departments of the European Organisation for Research and Treatment of Cancer (EORTC) radiation oncology group","volume":"155","author":"Willmann","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0135","doi-asserted-by":"crossref","unstructured":"Abrunhosa-Branquinho AN, Bar-Deroma R, Collette S, Clementel E, Liu Y, Hurkmans CW, et al. Radiotherapy quality assurance for the RTOG 0834\/EORTC 26053-22054\/NCIC CTG CEC.1\/CATNON intergroup trial \u201cconcurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p\/19q deleted anaplastic glioma\u201d: Individual case review analysis. Radiother Oncol : J Eur Soc Therap Radiol Oncol. 2018;127:292-8.","DOI":"10.1016\/j.radonc.2018.03.013"},{"key":"10.1016\/j.radonc.2023.110060_b0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2012.04.002","article-title":"Quality assurance in the EORTC 22033\u201326033\/CE5 phase III randomized trial for low grade glioma: the digital individual case review","volume":"103","author":"Fairchild","year":"2012","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0145","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2022.03.007","article-title":"Evaluating regional nodal irradiation allocation and association with oncologic outcomes in NSABP B-18, B-27, B-40, and B-41","volume":"113","author":"Mailhot Vega","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110060_b0150","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1470-2045(22)00482-X","article-title":"De-escalation of radiotherapy after primary chemotherapy in cT1\u20132N1 breast cancer (RAPCHEM; BOOG 2010\u201303): 5-year follow-up results of a Dutch, prospective, registry study","volume":"23","author":"de Wild","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.05.038","article-title":"Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines","volume":"150","author":"Mir","year":"2020","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0165","doi-asserted-by":"crossref","unstructured":"Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol : J Eur Soc Therap Radiol Oncol. 2016;118:205-8.","DOI":"10.1016\/j.radonc.2015.12.027"},{"key":"10.1016\/j.radonc.2023.110060_b0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2021.07.015","article-title":"Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast courses","volume":"162","author":"Kaidar-Person","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0175","article-title":"Postmastectomy radiation therapy planning after immediate implant-based reconstruction using the European Society for Radiotherapy and Oncology-Advisory Committee in radiation oncology practice consensus guidelines for target volume delineation","author":"Kaidar-Person","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0180","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2013.06.025","article-title":"Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0185","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2020.04.042","article-title":"Central review of radiation therapy planning among patients with breast-conserving surgery: Results from a quality assurance process integrated into the INSEMA trial","volume":"107","author":"Hildebrandt","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110060_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.radonc.2014.06.017","article-title":"Four years with FALCON - an ESTRO educational project: achievements and perspectives","volume":"112","author":"Eriksen","year":"2014","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2008.07.011","article-title":"Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial","volume":"90","author":"Poortmans","year":"2009","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0200","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2023.110060_b0205","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) Trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0210","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1\u20132 breast cancer patients presenting one or two metastatic sentinel lymph nodes: The SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: The SOUND randomized clinical trial","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0220","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/djab113","article-title":"Side effects 15 years after lymph node irradiation in breast cancer: Randomized EORTC trial 22922\/10925","volume":"113","author":"Poortmans","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2023.110060_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109698","article-title":"Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922\/10925","volume":"185","author":"Kaidar-Person","year":"2023","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0230","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2019.04.027","article-title":"The impact of chest wall boost on reconstruction complications and local control in patients treated for breast cancer","volume":"105","author":"Naoum","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110060_b0240","doi-asserted-by":"crossref","unstructured":"Dahn H, Boersma, L, de Ruysscher, D, Meattini, I, Offersen, BV, Pignol, JP, Aristei, C, Belkacemi, Y, Benjamin, D, Bese, N, Coles, C , Franco, P, Ho, A, Hol, S, Jagsi, R, Kirby, A Marrazzo, L, Marta, G, Moran, M, Nichol, A , Nissen, H, Strnad, V, Zissiadis, Y, Poortmans, P, Kaidar-Person, O. The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. Crit Rev Oncol \/ Hematol. 2021;Accepted for publication.","DOI":"10.1016\/j.critrevonc.2021.103391"},{"key":"10.1016\/j.radonc.2023.110060_b0245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2021.09.012","article-title":"A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer","volume":"164","author":"Kaidar-Person","year":"2021","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0250","doi-asserted-by":"crossref","unstructured":"Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, et al. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial. J Clin Oncol. 2020:JCO.20.01363.","DOI":"10.1200\/JCO.20.01363"},{"key":"10.1016\/j.radonc.2023.110060_b0255","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijrobp.2011.09.054","article-title":"Standardizing naming conventions in radiation oncology","volume":"83","author":"Santanam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110060_b0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.breast.2016.05.004","article-title":"Helical tomotherapy for bilateral breast cancer: Clinical experience","volume":"28","author":"Kaidar-Person","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2023.110060_b0265","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clon.2020.09.004","article-title":"Postmastectomy radiation therapy planning after immediate implant-based reconstruction using the European Society for Radiotherapy and Oncology-Advisory Committee in radiation oncology practice consensus guidelines for target volume delineation","volume":"33","author":"Kaidar-Person","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2023.110060_b0270","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2011.05.073","article-title":"Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting","volume":"100","author":"Weber","year":"2011","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2022.09.024","article-title":"Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial","volume":"177","author":"Thomsen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13014-022-02043-0","article-title":"Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters","volume":"17","author":"Maliko","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110060_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030751","article-title":"CANTO-RT: One of the largest prospective multicenter cohort of early breast cancer patients treated with radiotherapy including full DICOM RT data","volume":"15","author":"Sarrade","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.110060_b0290","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/ijc.34057","article-title":"CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer","volume":"151","author":"Allali","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2023.110060_b0295","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:38:18Z","timestamp":1741455498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023093672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":60,"alternative-id":["S0167814023093672"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110060","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110060"}}